Premium as high as 60%! AbbVie (ABBV.US) is planning to acquire Apogee (APGE.US) for $10.9 billion, with announcement expected as early as today.

According to Caijing Finance APP, it has been reported by knowledgeable sources that AbbVie (ABBV.US) is close to reaching an agreement to acquire Apogee Therapeutics (APGE.US), a developer of anti-inflammatory drugs, for nearly 11 billion US dollars. This deal is expected to be the largest strategic acquisition for the pharmaceutical giant since 2019.